SCHEMBL5743582

SCHEMBL5743582

Cc1ccc(F)c(-c2cc(CCO)no2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
NISCH Q9Y2I1 1/20 0.38
SLC9A1 P19634 1/20 0.38
NOTUM Q6P988 2/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CHRNB2 P17787 4/20 0.33
CHRNA4 P43681 4/20 0.33
HPGD P15428 1/20 0.33
CASP3 P42574 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6194978 0.92 NPC1 (0.40) NPC1RAB9ANISCHSLC9A1NOTUM
SCHEMBL1544615 0.88 NOTUM (0.49) NPC1RAB9ANISCHSLC9A1NOTUM
SCHEMBL4629766 0.84 NOTUM (0.48) NPC1RAB9ANOTUMMEN1KMT2A
SCHEMBL27788542 0.81 MAPT (0.44) NPC1RAB9ANISCHSLC9A1MEN1
SCHEMBL6195123 0.81 SLC9A1 (0.41) NPC1RAB9ANISCHSLC9A1MEN1
SCHEMBL4325035 0.80 NPC1 (0.40) NPC1RAB9ANISCHSLC9A1NOTUM
SCHEMBL6195151 0.79 NPC1 (0.41) NPC1RAB9ANISCHSLC9A1MEN1
SCHEMBL5743289 0.78 NPC1 (0.34) NPC1RAB9ANISCHSLC9A1MEN1
SCHEMBL6193588 0.76 MAPT (0.33) NPC1RAB9ANISCHSLC9A1MEN1
SCHEMBL27613693 0.76 NPC1 (0.36) NPC1RAB9ANISCHSLC9A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723144-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2006-11-22 EP disclosed
WO-2006014185-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2006-02-09 WO disclosed
EP-1536790-A2 OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 AstraZeneca AB (SE) 2005-06-08 EP disclosed
EP-1529045-A2 NEW COMPOUNDS Astra Zeneca AB (SE) 2005-05-11 EP disclosed
WO-2004014370-A2 OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 ASTRAZENECA AB (SE) 2004-02-19 WO disclosed
WO-2004014881-A2 '1,2,4'OXADIAZOLES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 ASTRA ZENECA AB (SE) 2004-02-19 WO disclosed